Skip to main content
. 2023 Aug 28;8(11):2482–2485. doi: 10.1016/j.ekir.2023.08.032

Figure 2.

Figure 2

The plot of eGFR versus time since capmatinib therapy. Each color represents an individual patient trajectory of eGFR up to 12 months after initiation of therapy and is overlaid by a bold line indicating fitted average eGFR versus time using a linear mixed model. The dotted lines indicate the 95% confidence intervals of the fixed effects. eGFR, estimated glomerular filtration rate.